New P1 trial
|
CD19 (CD19 Molecule) • KMT2A (Lysine Methyltransferase 2A) • CRLF2 (Cytokine Receptor Like Factor 2) • CD22 (CD22 Molecule) • HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • HLA-B (Major Histocompatibility Complex, Class I, B) • HLA-C (Major Histocompatibility Complex, Class I, C)
|
KMT2A rearrangement • MLL rearrangement • CD19 expression • CRLF2 rearrangement
|
Orca-T • firicabtagene autoleucel (CRG-022)